{"database": "lobbying", "table": "lobbying_activities", "rows": [[2683938, "29c1dd4d-8c36-4442-8a43-0a8e22a15a94", "Q3", "MEHLMAN CONSULTING, INC.", 284950, "ASCENSION HEALTH ALLIANCE", 2021, "third_quarter", "PHA", "340B Drug Pricing Program. \nFinancial support for providers for diagnosis and treatment related to COVID-19, coverage of COVID-19 related conditions, access to PPE and other materials and equipment related to the treatment of patients with COVID-19.\nThe Build Back Better Act, A bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2021-10-18T09:44:58.323000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2683938"], "units": {}, "query_ms": 0.33786892890930176, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}